VRCA - Verrica Pharmaceuticals Profile, Share Price, Market Analysis, Charts, Fundamentals - CSIMarket

Company Name, Ticker, Customers, else..

Verrica Pharmaceuticals Inc. (VRCA)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Price: $2.8400 $-0.11

-3.729%

Day's High:	$2.91	Week Perf:	1.79 %
Day's Low:	$ 2.77	30 Day Perf:	-25.46 %
Volume (M):	34	52 Wk High:	$ 13.64
Volume (M$):	$ 97	52 Wk Avg:	$6.88
Open:	$2.91	52 Wk Low:	$1.77

VRCA Charts & Quotes

VRCA Charts & Quotes

Company's Segments

Market Capitalization (Millions $)	78
Shares Outstanding (Millions)	28
Employees	-
Revenues (TTM) (Millions $)	1
Net Income (TTM) (Millions $)	-41
Cash Flow (TTM) (Millions $)	21
Capital Exp. (TTM) (Millions $)	0

Verrica Pharmaceuticals Inc.

Company Address: 44 West Gay Street West Chester 19380 PA
Company Phone Number: 453-3300 Stock Exchange / Ticker: NASDAQ VRCA

VRCA is expected to report next financial results on November 11, 2022.

Reports on Competition

List of Competitors

Competitors by Segment

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Stock Performances by Major Competitors

Year to Date	Decrease / Increase

• View Complete Report

News

Technology and Telecommunication Acquisition Corpo

Sales and Earnings Unchanged at Technology And Telecommunication Acquisition Corpo in the third quarter of 2022

In the third quarter of 2022 Technology And Telecommunication Acquisition Corpo eps of $0.02 per share compared to $ a year ago and from $0.00 per share from the previous quarter.

Hubilu Venture Corporation

Break-even by Hubilu Venture Corporation in the second quarter of 2022 earnings season announcement

Hubilu Venture Corporation recorded operating profit of $0.195403 millions, in the second quarter of 2022 earnings season, a progress from the operating surplus of $0.146331 millions, reported in second quarter of 2021

Advaxis Inc.

Losses Widen but Revenues Unchanged at Advaxis Inc in the third quarter of 2022

Company reports $-6.96 million loss, as impairment charges strip off $3.01 million from the third quarter of 2022 results.

Unique Logistics International Inc.

Break-even by Unique Logistics International Inc in the fourth quarter of 2021 release

In the fourth quarter of 2021 Unique Logistics International Inc reached break-even of $0.00 per share compared to $-0.00 a year ago and from $-0.01 per share from the previous quarter.

Quarta rad Inc.

An eye-catching drop in Sales at Quarta Rad Inc in the second quarter of 2022 earnings season

Quarta Rad Inc recorded operating deficit of $-0.01576 millions, in the second quarter of 2022 earnings season, a degradation from the operating surplus of $0.056298 millions, reported in second quarter of 2021

VRCA's Valuation	Current
Price to Earnings PE Ratio (TTM)	-
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	121.17
Price to Sales (Expected)	-
Price to Book	4.79
PEG (TTM)	-

VRCA's Financial Strength	Current
Quick Ratio	0.31
Working Capital Ratio	1.25
Leverage Ratio (MRQ)	2.88
Total Debt to Equity	2.59
Interest Coverage (TTM)	-
Debt Coverage (TTM)	-

Per Share	Current
Earnings (TTM)	-1.5 $
Revenues (TTM)	0.02 $
Cash Flow (TTM)	0.75 $
Cash	0.52 $
Book Value	0.59 $
Dividend (TTM)	0 $

VRCA's Efficiency	Current
Revenue per Employee (TTM)	-
Net Income per Employee (TTM)	-
Receivable Turnover Ratio (TTM)	-
Inventory Turnover Ratio (TTM)	-
Asset Turnover Ratio (TTM)	0.01

VRCA's Profitability Ratio	Current
Gross Margin (MRQ)	-
Operating Margin (MRQ)	-4262.15 %
Net Margin (MRQ)	-4751.4 %
Net Cash Flow Margin (MRQ)	-2325.7 %
Effective Tax Rate (TTM)	-

Management Effectiveness	Current
Return On Assets (TTM)	-
Return On Investment (TTM)	-
Return On Equity (TTM)	-
Dividend Yield	-
Pay out Ratio (TTM)	-

VRCA's Valuation
Price to Earnings PE Ratio (TTM)	-
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	121.17
Price to Sales (Expected)	-
Price to Book	4.79
PEG (TTM)	-

Per Share
Earnings (TTM)	-1.5 $
Revenues (TTM)	0.02 $
Cash Flow (TTM)	0.75 $
Cash	0.52 $
Book Value	0.59 $
Dividend (TTM)	0 $

VRCA's Financial Strength
Quick Ratio	0.31
Working Capital Ratio	1.25
Leverage Ratio (MRQ)	2.88
Total Debt to Equity	2.59
Interest Coverage (TTM)	-
Debt Coverage (TTM)	-

• View Valuation Comparisons

• View Growth Rates Comparisons

VRCA's Efficiency
Revenue per Employee (TTM)	-
Net Income per Employee (TTM)	-
Receivable Turnover Ratio (TTM)	-
Inventory Turnover Ratio (TTM)	-
Asset Turnover Ratio (TTM)	0.01

VRCA's Profitability Ratio
Gross Margin (MRQ)	-
Operating Margin (MRQ)	-4262.15 %
Net Margin (MRQ)	-4751.4 %
Net Cash Flow Margin (MRQ)	-2325.7 %
Effective Tax Rate (TTM)	-

Management Effectiveness
Return On Assets (TTM)	-53.97 %
Return On Investment (TTM)	-135.57 %
Return On Equity (TTM)	-142.38 %
Dividend Yield	-
Pay out Ratio (TTM)	-

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Verrica Pharmaceuticals's Segments

• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar LTC's Profile Stock Price LTC's Financials Business Description Fundamentals Charts & Quotes LTC's News Suppliers LTC's Competitors Customers & Markets Economic Indicators LTC's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Industries

At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets

At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071